Clinical Trial Update: A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether identifying undiagnosed atrial fibrillation in people aged 70+ reduces stroke risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: COMPLETED